Shopping Cart
- Remove All
- Your shopping cart is currently empty
Balugrastim (CG 10639), a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF), results from the genetic fusion of recombinant human serum albumin and G-CSF. It has applications in breast cancer research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Balugrastim (CG 10639), a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF), results from the genetic fusion of recombinant human serum albumin and G-CSF. It has applications in breast cancer research [1]. |
In vivo | Balugrastim (CG 10639) exhibits high plasma stability and good tolerability [1]. |
Alias | CG 10639 |
Cas No. | 527698-09-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.